Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
Lupus Nexus: developing a prospective registry, biorepository and data exchange platform to foster global collaborations, accelerate research innovation and advance precision medicine in lupus.
Journal: Lupus science & medicine
Published: March 26, 2026
Prospective SARS-CoV-2 additional vaccination in immunosuppressant-treated individuals with autoimmune diseases in a randomized controlled trial.
Journal: JCI insight
Published: November 25, 2025
A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases.
Journal: ACR open rheumatology
Published: July 22, 2025
Prospective SARS-CoV-2 Booster Vaccination in Immunosuppressant-Treated Systemic Autoimmune Disease Patients in a Randomized Controlled Trial.
Journal: medRxiv : the preprint server for health sciences
Published: April 08, 2025
Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics.
Journal: Rheumatology (Oxford, England)
Published: January 28, 2025
Patient outcomes from implementing a shared decision-making aid for systemic lupus erythematosus: a prospective implementation study.
Journal: The Lancet. Rheumatology
Published: January 28, 2025
Time required to implement a computerized patient decision aid for lupus in outpatient visits.
Journal: Implementation science communications
Published: January 15, 2025
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.
Journal: Seminars in arthritis and rheumatism
Published: November 07, 2024
Screening for Social Determinants of Health in Patients With Systemic Lupus Erythematosus: A Point-of-Care Feasibility Study.
Journal: Arthritis care & research
Published: October 10, 2024
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.
Journal: The Lancet. Infectious diseases
Published: October 01, 2024
The National Academies' 2024 Diagnostic Criteria for Long COVID: Concerns That Could Affect the Rheumatology Community.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: September 17, 2024
Patient-Reported Social Risk Factor Screening Among Rheumatology Outpatients.
Journal: ACR open rheumatology
Published: August 19, 2024
Last Updated: 09/26/2026